FDA Drug Application (021610) for OPANA ER by ENDO PHARMS

Back to FDA Applications sponsored by ENDO PHARMS

Application Number021610
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameOPANA ER
Active IngredientOXYMORPHONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient OXYMORPHONE HYDROCHLORIDE4


Back to FDA Applications sponsored by ENDO PHARMS